C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction

European Journal of Preventive Cardiology

Volumn 7, Issue 1, 2000, Pages 37-40

  Annichino Bizzacchi, Joyce M ^a   Saad, Sara T O ^a   Arruda, Valder R ^a   Ramires, José A F ^b   Siqueira, Lucia H ^a   Chiaparini, Luís C ^a   Mansur, Antonio P ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

C282Y; hemochromatosis; mutation; myocardial infarction

Indexed keywords

HLA ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HEART INFARCTION; HEMOCHROMATOSIS; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84992861153     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748730000700107     Document Type: Article

References (14)

1. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799–1805.
2. Feder JN, Gnirke A, Thomas W. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genet 1996; 13: 399–408.
3. Pang JS, Jiang M, Chen Y, Wang F, Wang D, Chu S. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 1996; 97: 2204–2212.
4. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1991; 1: 1293–1294.
5. Salonen JT, Nyyssönen K, Korpela H. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803–811.
6. Magnusson MK, Sigfusson N, Sigvaldason H. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994; 89: 102–108.
7. Ascherio A, Willet WC, Rimm EB. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89: 967–974.
8. Aronow WS. Serum ferritin is not a risk factor for coronary artery disease in men and women aged > 62 years. Am J Cardiol 1993; 72: 347–348.
9. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I Epidemiologic Follow-up study. Am J Epidemiol 1994; 139: 704–712.
10. Sempos CT, Looker AC, Gillum RF. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330: 1119–1124.
11. Morrison HI, Semenciw RM, Mao Y. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994; 5: 243–246.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Second edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
13. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275–278.
14. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677 $ Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1977; 77: 818–821.